Safety of stimulant medications for attention deficit hyperactivity disorder in paediatric congenital heart disease

Chung, Lorraine M., Hariharan, Gopakumar, and Varma, Suraj (2023) Safety of stimulant medications for attention deficit hyperactivity disorder in paediatric congenital heart disease. Journal of Paediatrics and Child Health, 59 (3). pp. 580-588.

PDF (Published Version) - Published Version
Restricted to Repository staff only

DOI: 10.1111/jpc.16380

View at Publisher Website: https://doi.org/10.1111/jpc.16380

Abstract

Aim: To review current literature regarding the safety of stimulant medications for treatment of attention deficit hyperactivity disorder in paediatric congenital heart disease (CHD) patients.

Methods: Embase, MEDLINE complete, CINAHL complete and Psychology and Behavioural Sciences Collection were searched for relevant articles from January 1980 to July 2022.

Results: One hundred and three articles were identified during the initial search after removal of duplicates. Thirty-five articles were selected for review and 11 were included as relevant to the clinical question.

Conclusions: Stimulant medications are safe in patients with underlying CHD. In mild congenital cardiac conditions (ventricular septal defect, atrial septal defect and isolated semilunar valve disease), paediatricians can safely initiate stimulant therapy. With complex CHD cases, cardiology opinion is recommended prior to starting stimulants.


Item ID:	78378
Item Type:	Article (Research - C1)
ISSN:	1440-1754
Keywords:	attention deficit hyperactivity disorder, cardiology, heart defect, paediatrics, stimulant
Copyright Information:	© 2023 Paediatrics and Child Health Division (The Royal Australasian College of Physicians
Date Deposited:	12 Jul 2023 03:55
FoR Codes:	32 BIOMEDICAL AND CLINICAL SCIENCES > 3213 Paediatrics > 321399 Paediatrics not elsewhere classified @ 100%
	More Statistics

Actions (Repository Staff Only)

Item Control Page